The ten-year financing facility from SEK will enable Mölnlycke to further expand its operations and accelerate strategic development initiatives globally.

Mölnlycke is a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures. The company develops, manufactures and sells products and solutions that are used daily by hospitals, healthcare providers and patients in over 100 countries around the world.  With a strong global footprint, the company plays a critical role in advancing healthcare worldwide.

“We are very pleased to support Mölnlycke Health Care, an industry leader with a strong international presence and a key contributor to Swedish exports,” says Klas Lindgren Dansbo, Head of Large Corporates at SEK. “We’re proud to be part of their continued growth journey.”

“We have an exciting path ahead of us to navigate and support the evolving healthcare landscape. As we advance into the next phase of our customer centric strategy, our agreement with SEK marks a pivotal step in supporting our future growth, “says Zlatko Rihter, CEO, Mölnlycke.